SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-002392
Filing Date
2015-05-14
Accepted
2015-05-14 16:00:37
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT oxis_10q.htm 10-Q 523607
2 CERTIFICATION ex_311.htm EX-31.1 14000
3 CERTIFICATION ex_321.htm EX-32.1 8223
  Complete submission text file 0001354488-15-002392.txt   2264196

Data Files

Seq Description Document Type Size
4 oxis-20150331.xml EX-101.INS 216320
5 oxis-20150331.xsd EX-101.SCH 16883
6 oxis-20150331_cal.xml EX-101.CAL 32473
7 oxis-20150331_def.xml EX-101.DEF 42386
8 oxis-20150331_lab.xml EX-101.LAB 145585
9 oxis-20150331_pre.xml EX-101.PRE 109443
Mailing Address 4830 W KENNEDY BLVD SUITE 600 TAMPA FL 33609
Business Address 4830 W KENNEDY BLVD SUITE 600 TAMPA FL 33609 (800) 304-9888
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 15862714
SIC: 2834 Pharmaceutical Preparations